TITLE

Human Immunodeficiency Virus--Associated Lipoatrophy: Letting the Genome Out of the Bottle

AUTHOR(S)
Lichtenstein, Kenneth A.
PUB. DATE
March 2008
SOURCE
Journal of Infectious Diseases;3/15/2008, Vol. 197 Issue 6, p784
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on the benefits of antiretrovial therapy in treating human immunodeficiency virus (HIV) infection. He discusses the potential role of genetic polymorphisms in predisposing HIV-infected patients who receive highly active antiretroviral therapy (HAART). The author believes that antiretroviral therapy has enhanced the quality of life of patients and provided hope for all HIV-infected individuals who have access to such medicines.
ACCESSION #
31571105

 

Related Articles

  • Increased risk of deep neck infection among HIV-infected patients in the era of highly active antiretroviral therapy--a population-based follow-up study. Ching-Feng Liu; Shih-Feng Weng; Yung-Song Lin; Chih-Sheng Lin; Ching-Feng Lien; Jhi-Joung Wang // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: Deep neck infections (DNIs) in HIV-infected patients often produce severe complications, even death. Data on the incidence rates and risks of DNI among HIV-infected patients are scarce, particularly with the widespread use of highly active antiretroviral therapy (HAART). We evaluated...

  • Highly Active Antiretroviral Therapy Use and HIV Transmission Risk Behaviors Among Individuals Who Are HIV Infected and Were Recently Released From Jail. Clements-Nolle, Kristen; Marx, Rani; Pendo, Michael; Loughran, Eileen; Estes, Milton; Katz, Mitchell // American Journal of Public Health;Apr2008, Vol. 98 Issue 4, p661 

    We evaluated highly active antiretroviral therapy (HAART) use and risk behaviors among 177 inmates who were HIV infected and were released and reincarcerated in San Francisco, Calif, jails over a 12-month period. During the month preceding reincarceration, HIV transmission risk behaviors were...

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study. Teshome, Wondu; Tefera, Ambachew // BMC Immunology;9/17/2015, Vol. 16 Issue 1, p1 

    Background: Timely detection of treatment failure with subsequent switch to second-line regimen reduces mortality among HIV infected people on antiretroviral therapy (ART). This paper aims to investigate the detection of immunological treatment failure and switch rate to second line regimen in...

  • Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans. Nanzigu, Sarah; Kiguba, Ronald; Kabanda, Joseph; Mukonzo, Jackson K.; Waako, Paul; Kityo, Cissy; Makumbi, Fred // HIV/AIDS - Research & Palliative Care;2013, Vol. 5, p309 

    Introduction: CD4 T lymphocytes remain the surrogate measure for monitoring HIV progress in resource-limited settings. The absolute CD4 cell counts form the basis for antiretroviral therapy (ART) initiation and monitoring among HIV-infected adults. However, the rate of CD4 cell change differs...

  • IMPACT OF ANTIRETROVIRAL THERAPY ON SURVIVAL IN HIV INFECTED PATIENTS. Arbune, Manuela // Romanian Journal of Infectious Diseases;2009, Vol. 12 Issue 4, p211 

    The main objective of the study is to compare the survival time on antiretroviral treated HIV patients (TG) versus untreated group (NTG). Medical records of confirmed HIV patients between 1990-2008 in Galati County were retrospectively studied. From 600 cases 279 died, 255 are still living and...

  • Effect of Free Treatment and Surveillance on HIV-Infected Persons Who Have Tuberculosis, Taiwan, 1993-2006. Shu-Hui Tseng; Dah-Shyong Jiang, Donald; Hao-Seong Hoi; Hsiu-Yun Lo; Kao-Pin Hwang // Emerging Infectious Diseases;Feb2009, Vol. 15 Issue 2, p332 

    In 1997, Taiwan made highly active antiretroviral therapy (HAART) available without cost to HIV-infected persons; in 2001, a national web-based surveillance system was implemented. Healthcare workers use the system to monitor patients' conditions and can intervene when necessary. Free HAART,...

  • Real Life HAART Efficacy in Chronically HIV-1 Infected Children 15-Year Follow-Up. Monpoux, Fabrice; Rubio, Amandine; Sakarovitch, Charlotte; Fontas, Eric; Cottalorda-Dufayard, Jacqueline; Pradier, Christian // Journal of AIDS & Clinical Research;2012, Vol. 3 Issue 8, Special section p1 

    Background: It is now widely accepted that the antiretroviral first line-treatment basis in HIV-1 infected children is a combination of 2 nucleoside reverse transcriptase inhibitors and 1 protease inhibitor or 1 non NRTI. However, after few months or years, some patients presented with...

  • A Measurement Model of Medication Adherence to Highly Active Antiretroviral Therapy and Its Relation to Viral Load in HIV-Positive Adults. Llabre, Maria M.; Weaver, Kathryn E.; Durán, Ron E.; Antoni, Michael H.; McPherson-Baker, Shvawn; Schneiderman, Neil // AIDS Patient Care & STDs;Oct2006, Vol. 20 Issue 10, p701 

    This study compared a multiple method measurement model of highly active antiretroviral therapy (HAART) adherence with single-method models to determine optimal validity in predicting HIV viral load. Repeated measures of antiretroviral adherence were collected over a 15-month period using three...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics